Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study.
d'Andrea G, Miuli A, Pettorruso M, Cavallotto C, Marrangone C, Cocco A, De Filippis S, Martiadis V, Andriola I, Barlati S, Vita A, Dell'Osso BM, Sensi SL, Di Lorenzo G, Martinotti G. d'Andrea G, et al. Among authors: de filippis s. J Affect Disord. 2024 Dec 15;367:583-588. doi: 10.1016/j.jad.2024.09.004. Epub 2024 Sep 2. J Affect Disord. 2024. PMID: 39233241
Neurological soft signs discriminate schizophrenia from bipolar disorder.
Rigucci S, Dimitri-Valente G, Mandarelli G, Manfredi G, Comparelli A, De Filippis S, Gherardelli S, Bersani G, Girardi P, Ferracuti S. Rigucci S, et al. Among authors: de filippis s. J Psychiatr Pract. 2014 Mar;20(2):147-53. doi: 10.1097/01.pra.0000445250.20875.0e. J Psychiatr Pract. 2014. PMID: 24638050
Identification of clinical phenotypes in schizophrenia: the role of lurasidone.
Riva MA, Albert U, de Filippis S, Vita A, De Berardis D. Riva MA, et al. Among authors: de berardis d, de filippis s. Ther Adv Psychopharmacol. 2021 May 10;11:20451253211012250. doi: 10.1177/20451253211012250. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 34025981 Free PMC article. Review.
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study).
Martinotti G, Vita A, Fagiolini A, Maina G, Bertolino A, Dell'Osso B, Siracusano A, Clerici M, Bellomo A, Sani G, d'Andrea G, Chiaie RD, Conca A, Barlati S, Di Lorenzo G, De Fazio P, De Filippis S, Nicolò G, Rosso G, Valchera A, Nucifora D, Di Mauro S, Bassetti R, Martiadis V, Olivola M, Belletti S, Andriola I, Di Nicola M, Pettorruso M, McIntyre RS, di Giannantonio M; REAL-ESK Study Group. Martinotti G, et al. Among authors: de fazio p, de filippis s. J Affect Disord. 2022 Dec 15;319:646-654. doi: 10.1016/j.jad.2022.09.043. Epub 2022 Sep 24. J Affect Disord. 2022. PMID: 36167246
Treatment persistence with aripiprazole once monthly: a 4-year follow-up.
Fagiolini A, Aguglia E, Ballerini A, Callista G, Carpiniello B, Clerici M, Corrivetti G, Cuomo A, De Fazio P, De Filippis S, De Giorgi S, Goracci A, La Barbera D, Mencacci C, Montagnani G, Pigato G, Vannucchi J, Vita A. Fagiolini A, et al. Among authors: de fazio p, de filippis s, de giorgi s. Ann Gen Psychiatry. 2022 Sep 29;21(1):39. doi: 10.1186/s12991-022-00416-z. Ann Gen Psychiatry. 2022. PMID: 36175924 Free PMC article.
124 results